HOLX
HOLOGIC INC
Nasdaq: HOLX · Marlborough, MA
$76.01+0.00 (+0.00%)Closed
Market Cap$16.97B
Cash$2.17Bmost recent
Runwayprofitable
P/E (TTM)30.5EPS $2.49
52-Wk Range$52.73 – $76.01
Avg Volume3.2M3-month
Price & Trading Activity

Daily close with catalyst overlays and trading volume

$76.01-0.3%
Pipeline

Drug candidates sponsored by HOLOGIC · ClinicalTrials.gov

31 drugs · 31 trials
PhaseDrug / CandidateIndicationsStatusNext CompletionTrials
Phase 2Unnamed
DCIS
Completed
2006-01past
1
Phase 2Unnamed
Brain Metastases
Completed
2007-03past
1
N/AUnnamed
Reproductive Sterilization
Terminated
2005-12past
1
N/AUnnamed
Breast Cancer
Completed
2007-05past
1
N/AUnnamed
Breast Cancer
Completed
2008-09past
1
N/AUnnamed
Abnormal Uterine Bleeding+1 more
Completed
2009-03past
1
N/AUnnamed
Uterine Fibroids+1 more
Completed
2010-07past
1
N/AUnnamed
Breast Cancer
Completed
2010-09past
1
N/AUnnamed
Breast Cancer
Completed
2011-09past
1
N/AUnnamed
Uterine Fibroids+1 more
Completed
2012-01past
1
N/AUnnamed
Uterine Fibroids+1 more
Completed
2013-05past
1
N/AUnnamed
Breast Cancer
Completed
2013-11past
1
N/AUnnamed
Hepatitis C
Completed
2015-04past
1
N/AUnnamed
Hepatitis B, Chronic
Completed
2016-02past
1
N/AUnnamed
Pre-term Birth
Unknown
2016-07past
1
N/AUnnamed
Herpes Simplex Infections
Completed
2016-08past
1
N/AUnnamed
Chlamydia Trachomatis+1 more
Terminated
2017-03-01past
1
N/AUnnamed
Breast Cancer
Completed
2018-06-18past
1
N/AUnnamed
Menorrhagia
Unknown
2018-10past
1
N/AUnnamed
Breast Cancer Female
Completed
2018-11-20past
1
N/AUnnamed
Breast Cancer Female
Completed
2019-03-19past
1
N/AUnnamed
Intra-Amniotic Infection of Foetus
Withdrawn
2019-12-31past
1
N/AUnnamed
Human Papilloma Virus Infection
Completed
2021-06past
1
N/AUnnamed
Cervical Cancer Screening
Completed
2021-09-27past
1
N/AUnnamed
Breast Cancer
Completed
2022-04-18past
1
N/AUnnamed
Cervical Cancer Screening
Unknown
2023-12-31past
1
N/AUnnamed
Mammography
Recruiting
2026-03-31past
1
N/AUnnamed
Breast Screening
Recruiting
2026-03-31past
1
N/AUnnamed
Urgent Urinary Incontinence
Suspended
2030-02
1
N/AUnnamed
Women Contraception
Terminated—1
N/AUnnamed
Preterm Delivery
Completed—1
Valuation

Risk-adjusted NPV

Loading pipeline…
Peer comparison

Cohort check

No peer cohort defined for HOLX. Cohorts currently cover gene editing, mRNA, rare-disease gene therapy, and large-cap biotech — more coming soon.